Miriam Isola - Concepedia

Author

Miriam Isola

University of Udine ORCID

Also Known As

Isola Miriam, M Isola, M. G. Isola, M. Isola, MIRIAM ISOLA, Miriam ISOLA, Miriam Isola, Miriam, Isola

255

Publications

7.4K

Citations

H-Index

245

Concepts

All Affiliations

University of Udine Ospedale Santa Maria della Misericordia di Udine Istituti di Ricovero e Cura a Carattere Scientifico University of Verona IRCCS Eugenio Medea

About

Miriam Isola is an author at University of Udine specializing in medicine, health sciences, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	53	2.2K
2	Health Sciences	14	15	702
3	Engineering	4	4	131
4	Public Health	3	3	67
5	Natural Sciences	1	1	10

Miriam Isola

140

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis Salvatore De Vita, Luca Quartuccio, Miriam Isola, Arthritis & Rheumatism	2011	396
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients Maddalena Peghin, Alvisa Palese, Margherita Venturini, Clinical Microbiology and Infection Clinical Infectious DiseaseCovid-19 PandemicAcute InfectionPost-covid-19 Symptoms 6Covid-19 Epidemiology	2021	323
Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients Tamara Ius, Miriam Isola, Riccardo Budai, Journal of neurosurgery	2012	288
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia Francesco Zaja, Michele Baccarani, Patrizio Mazza, Blood	2010	256
Preliminary classification criteria for the cryoglobulinaemic vasculitis Salvatore De Vita, Franca Soldano, Miriam Isola, Annals of the Rheumatic Diseases	2011	153
Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study Luca Quartuccio, Miriam Isola, Chiara Baldini, Journal of Autoimmunity Lymphoid NeoplasiaAutoimmune DiseaseSjögren’s SyndromeMedicineHematology	2013	151
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis Michela Bulfoni, Lorenzo Gerratana, Fabio Del Ben, Breast Cancer Research	2016	144
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands Luca Quartuccio, S. Salvin, Martina Fabris, Lara D. Veeken	2012	140
Efficacy and safety of belimumab given for 12 months in primary Sjögren’s syndrome: the BELISS open-label phase II study Salvatore De Vita, Luca Quartuccio, Raphaèle Séror, Lara D. Veeken	2015	140
Low‐dose rituximab in adult patients with primary immune thrombocytopenia Francesco Zaja, Nicola Vianelli, Stefano Volpetti, European Journal Of Haematology	2010	124

Page 1